THRDThird Harmonic Bio, Inc.

Nasdaq thirdharmonicbio.com


$ 14.23 $ 1.31 (10.14 %)    

Thursday, 16-May-2024 15:59:52 EDT
QQQ $ 452.40 $ -0.32 (-0.07 %)
DIA $ 398.83 $ -0.29 (-0.07 %)
SPY $ 529.00 $ 0.16 (0.03 %)
TLT $ 91.64 $ 0.02 (0.02 %)
GLD $ 222.66 $ 0.42 (0.19 %)
$ 14.23
$ 13.77
$ 14.09 x 100
$ 0.00 x 0
$ 13.56 - $ 14.23
$ 4.33 - $ 14.23
141,999
na
572.23M
$ 0.67
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-15-2024 03-31-2024 10-Q
2 03-26-2024 12-31-2023 10-K
3 11-09-2023 09-30-2023 10-Q
4 08-10-2023 06-30-2023 10-Q
5 05-11-2023 03-31-2023 10-Q
6 03-29-2023 12-31-2022 10-K
7 11-09-2022 09-30-2022 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 third-harmonic-bio-q1-2024-adj-eps-020-beats-031-estimate

Third Harmonic Bio (NASDAQ:THRD) reported quarterly losses of $(0.20) per share which beat the analyst consensus estimate of $(...

 third-harmonic-bio-q4-eps-017-beats-031-estimate

Third Harmonic Bio (NASDAQ:THRD) reported quarterly losses of $(0.17) per share which beat the analyst consensus estimate of $(...

 third-harmonic-bio-fy23-eps-078-vs-245-yoy

Summary of Financial ResultsCash Position: Cash and cash equivalents totaled $269.1 million as of December 31, 2023. Based on t...

 third-harmonic-bio-appoints-christopher-murphy-as-chief-financial-and-business-officer-and-provides-business-update

Chris brings extensive enterprise-level leadership experience in business development, commercial operations, and corporate str...

 third-harmonic-bio-q3-eps-061-misses-027-estimate

Third Harmonic Bio (NASDAQ:THRD) reported quarterly losses of $(0.61) per share which missed the analyst consensus estimate of ...

 third-harmonic-bio-inc-files-for-mixed-shelf-of-up-to-400m

-SEC Filing

 morgan-stanley-maintains-equal-weight-on-third-harmonic-bio-raises-price-target-to-7

Morgan Stanley analyst Michael Ulz maintains Third Harmonic Bio (NASDAQ:THRD) with a Equal-Weight and raises the price targe...

 third-harmonic-bio-announces-q2-2023-financial-results-financial-position-with-cash-and-cash-equivalents-totaling-2781m-as-of-june-30-2023

Summary of Financial Results Cash Position: Cash and cash equivalents totaled $278.1 million as of June 30, 2023. Based on the...

 third-harmonic-bio-announces-next-generation-oral-kit-inhibitor-product-candidate-thb335

THB335 retains selectivity and potency of first-generation oral KIT inhibitor, THB001, with differentiated metabolic, distribut...

 correction-third-harmonic-bio-q1-eps-081-misses-035-estimate

Third Harmonic Bio (NASDAQ:THRD) reported quarterly losses of $(0.81) per share which missed the analyst consensus estimate of ...

 third-harmonic-bio-q1-eps-081-misses-035-estimate

Third Harmonic Bio (NASDAQ: THRD) reported quarterly losses of $(0.81) per share which missed the analyst consensus estimate of...

 top-5-health-care-stocks-that-may-rally

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

 5-cheapest-health-care-stocks-you-should-think-about

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

 5-cheapest-health-care-stocks-you-should-think-about

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

 top-5-health-care-stocks-that-may-surge

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

 stocks-that-hit-52-week-lows-on-wednesday

  On Wednesday, 152 stocks made new 52-week lows.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION